These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31013272)

  • 1. Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures.
    Warsinske H; Vashisht R; Khatri P
    PLoS Med; 2019 Apr; 16(4):e1002786. PubMed ID: 31013272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
    Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
    JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring.
    Bayaa R; Ndiaye MDB; Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Nasrin R; Ranaivomanana P; Raherinandrasana AH; Rakotonirina J; Rasolofo V; Delogu G; De Maio F; Goletti D; Endtz H; Ader F; Hamze M; Ismail MB; Pouzol S; Rakotosamimanana N; Hoffmann J;
    Sci Rep; 2021 Jul; 11(1):13646. PubMed ID: 34211042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis.
    Ma S; Peng P; Duan Z; Fan Y; Li X
    J Immunol Res; 2023; 2023():7829286. PubMed ID: 37228444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis.
    Gupta RK; Turner CT; Venturini C; Esmail H; Rangaka MX; Copas A; Lipman M; Abubakar I; Noursadeghi M
    Lancet Respir Med; 2020 Apr; 8(4):395-406. PubMed ID: 31958400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis.
    Wang S; He L; Wu J; Zhou Z; Gao Y; Chen J; Shao L; Zhang Y; Zhang W
    Front Immunol; 2019; 10():2948. PubMed ID: 31921195
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of the Cepheid 3-gene Host Response Fingerstick Blood Test (MTB-HR) on rapid diagnosis of tuberculosis.
    Wu X; Tan G; Ma J; Yang J; Guo Y; Lu H; Ke H; Li M; Tang YW; Sha W; Yu F
    Emerg Microbes Infect; 2023 Dec; 12(2):2261561. PubMed ID: 37848021
    [No Abstract]   [Full Text] [Related]  

  • 8. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.
    Burel JG; Singhania A; Dubelko P; Muller J; Tanner R; Parizotto E; Dedicoat M; Fletcher TE; Dunbar J; Cunningham AF; Lindestam Arlehamn CS; Catanzaro DG; Catanzaro A; Rodwell T; McShane H; O'Shea MK; Peters B
    Tuberculosis (Edinb); 2021 Dec; 131():102127. PubMed ID: 34555657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study.
    Turner CT; Gupta RK; Tsaliki E; Roe JK; Mondal P; Nyawo GR; Palmer Z; Miller RF; Reeve BW; Theron G; Noursadeghi M
    Lancet Respir Med; 2020 Apr; 8(4):407-419. PubMed ID: 32178775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
    Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
    J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is interleukin-2 an optimal marker for diagnosing tuberculosis infection? A systematic review and meta-analysis.
    Qiu X; Wang H; Tang Y; Su X; Ge L; Qu Y; Mu D
    Ann Med; 2020 Nov; 52(7):376-385. PubMed ID: 32700645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach.
    Natarajan S; Ranganathan M; Hanna LE; Tripathy S
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
    Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
    Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood RNA signatures outperform CRP triage of tuberculosis lymphadenitis and pericarditis.
    Mann T; Minnies S; Gupta RK; Reeve BW; Nyawo G; Palmer Z; Naidoo C; Doubell A; Pecararo A; John TJ; Schubert P; Calderwood CJ; Chandran A; Theron G; Noursadeghi M
    medRxiv; 2024 Jul; ():. PubMed ID: 38946942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New genetic biomarkers from transcriptome RNA-sequencing for Mycobacterium tuberculosis complex and Mycobacterium avium complex infections by bioinformatics analysis.
    Jia Q; Wu Y; Huang Y; Bai X
    Sci Rep; 2024 Jul; 14(1):17385. PubMed ID: 39075154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
    Bodkin N; Ross M; McClain MT; Ko ER; Woods CW; Ginsburg GS; Henao R; Tsalik EL
    Genome Med; 2022 Feb; 14(1):18. PubMed ID: 35184750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TB.
    Leong S; Zhao Y; Ribeiro-Rodrigues R; Jones-López EC; Acuña-Villaorduña C; Rodrigues PM; Palaci M; Alland D; Dietze R; Ellner JJ; Johnson WE; Salgame P
    Tuberculosis (Edinb); 2020 Jan; 120():101898. PubMed ID: 32090859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.